FDA Advisory Panel Recommends Novavax Vaccine for Use in the US 

June 8, 2022 by Alexa Hornbeck
FDA Advisory Panel Recommends Novavax Vaccine for Use in the US 
FILE - In this image provided by the Serum Institute of India, vials of freshly manufactured Novavax COVID-19 vaccines wait to be labeled in 2022, in Pune, India. The more traditional kind of COVID-19 vaccine moved a step closer to the U.S. market Tuesday, June 7, 2022. Advisers to the Food and Drug Administration voted to back shots made by Novavax for U.S. adults. If the FDA ultimately agrees, Novavax's option could become the nation's fourth COVID-19 vaccine. (Serum Institute of India for Novavax via AP, File)

The U.S. Food and Drug Administration recommended an emergency use authorization for a COVID-19 vaccine from Novavax, Inc. on Tuesday, the second non-mRNA–based vaccine to be used in the U.S.

The FDA held an all-day Vaccines and Related Biological Products Advisory Committee meeting on June 7, and a panel of vaccine experts voted 21-0, with one abstention, in favor of the vaccine for those 18 and older. 

Similar to flu vaccines, the Novavax shot uses recombinant proteins grown in cell cultures developed by the biotech company based in Gaithersburg, Maryland. 

Global health experts believe EUA approval from the FDA for the Novavax COVID-19 vaccine could potentially help change the minds of people who are still vaccine hesitant in the United States based on concerns over the mRNA technology used in other vaccines. 

Results from a February phase 3 clinical trial in the U.K. also show it is 83% effective against all COVID-19 infections, and 100% effective at combating severe disease.

Alexa can be reached at [email protected]


A+
a-

In The News

Health

Voting

Health

September 29, 2023
by Jesse Zucker
Immunity-Boosting Superfoods for Cold and Flu Season

With the cooler weather rolling in, cold and flu season is upon us. If you’ve ever reached for some vitamin... Read More

With the cooler weather rolling in, cold and flu season is upon us. If you’ve ever reached for some vitamin C after coughing and sneezing, you may have wished you had thought about boosting your immune system sooner. Here we’ll break down the science around some... Read More

September 28, 2023
by Jesse Zucker
How to Stay Active and Healthy as the Seasons Change

When you’re in an outdoor exercise routine, the changing seasons can dampen your plans. Do you enjoy long walks, runs... Read More

When you’re in an outdoor exercise routine, the changing seasons can dampen your plans. Do you enjoy long walks, runs or bike rides along the mall while soaking up vitamin D from the sun? Did you love swimming laps at the D.C. public pools all summer... Read More

September 27, 2023
by Dan McCue
How a Government Shutdown Would Affect Federal Health Programs

WASHINGTON — With uncertainty continuing to swirl around Capitol Hill, conversations have begun to focus not on if there will... Read More

WASHINGTON — With uncertainty continuing to swirl around Capitol Hill, conversations have begun to focus not on if there will be a partial shutdown of the federal government come midnight on Saturday, but on how that almost inevitable shutdown will affect a wide range of federal... Read More

September 27, 2023
by Dan McCue
CDC Resets Flu Shot Messaging

ATLANTA — The Centers for Disease Control and Prevention has launched a new public relations campaign aimed at resetting public... Read More

ATLANTA — The Centers for Disease Control and Prevention has launched a new public relations campaign aimed at resetting public expectations around the influenza vaccine and clearing up long-standing misapprehensions about the shot. The new campaign, called “Wild to Mild,” was created based on suggestions garnered... Read More

September 27, 2023
by Dan McCue
Nearly 7% of Americans Say They Have Had Long COVID

ATLANTA — Nearly 7% of Americans participating in a new survey said they’ve had long COVID in the past year,... Read More

ATLANTA — Nearly 7% of Americans participating in a new survey said they’ve had long COVID in the past year, and 3.4% said they had it “currently,” according to the Centers for Disease Control and Prevention's National Center for Health Statistics. In a series of related... Read More

Injection-Free Diabetes Control May Be Within Reach

CAMBRIDGE, Mass. — Researchers at the Massachusetts Institute of Technology have designed a new implantable device to help in the... Read More

CAMBRIDGE, Mass. — Researchers at the Massachusetts Institute of Technology have designed a new implantable device to help in the treatment of Type 1 diabetes. One promising approach to treating Type 1 diabetes is implanting pancreatic islet cells that can produce insulin when needed, which can... Read More

News From The Well
scroll top